From Financial Modeling Prep: 2025-01-07 12:19:00

Evercore ISI analysts upgraded Laboratory Corporation of America (NYSE:LH) to Outperform with a price target of $265, citing optimism for above-consensus EPS growth in 2025 driven by base testing demand and margin expansion.

LabCorp’s core diagnostics business is expected to sustain 3%-4% organic volume growth in 2025 despite a slight softening in overall healthcare utilization, with testing demand remaining solid.

Invitae is expected to become slightly accretive in 2025, contributing $0.03 to annual EPS, driven by revenue growth, cost synergies, and diagnostics margin expansion.

LabCorp’s overall EPS growth in 2025 is projected to exceed the company’s long-term target range of 8.5%-11.5%, reflecting a strong operational trajectory.



Read more at Financial Modeling Prep:: Laboratory Corporation of America Upgraded to Outp…